PURPOSE: Previous studies have shown that tumors less than 1 mm diameter derived from HT29 colorectal cancer cells are extremely hypoxic when grown intraperitoneally or intradermally in nude mice, whereas those of greater size (approximately 1-4 mm diameter) are not significantly hypoxic. The object of this study was to determine if digital autoradiography using the radiolabeled hypoxia imaging tracer iodo-azomycin galactopyranoside ((131)I-IAZGP) could detect hypoxia in this model. METHODS: Microscopic HT29 tumors were grown as disseminated peritoneal disease and intradermally in nude mice. Tumors ranged in size from a few hundred microns to several millimeters in diameter. Animals were intravenously administered (131)I-IAZGP and pimonidazole 2 h before sacrifice. Following sacrifice, the intratumoral distribution of (131)I-IAZGP was assessed by digital autoradiography and compared with immunofluorescence microscopic images of pimonidazole binding and carbonic anhydrase IX (CAIX) expression. RESULTS: The distributions of (131)I-IAZGP, pimonidazole, and CAIX expression were similar. Tumors less than 1 mm diameter displayed high (131)I-IAZGP uptake; these tumors also stained strongly for pimonidazole and CAIX. Larger tumors (approximately 1-4 mm diameter) were not significantly hypoxic and had low (131)I-IAZGP accumulation. CONCLUSION: (131)I-IAZGP can detect hypoxia in microscopic tumors. Microscopic tumors are useful models for the validation of hypoxia radiotracers, and digital autoradiography is an appropriate technique for studying the distribution of hypoxia radiotracers in microscopic tumors.
PURPOSE: Previous studies have shown that tumors less than 1 mm diameter derived from HT29colorectal cancer cells are extremely hypoxic when grown intraperitoneally or intradermally in nude mice, whereas those of greater size (approximately 1-4 mm diameter) are not significantly hypoxic. The object of this study was to determine if digital autoradiography using the radiolabeled hypoxia imaging tracer iodo-azomycin galactopyranoside ((131)I-IAZGP) could detect hypoxia in this model. METHODS: Microscopic HT29 tumors were grown as disseminated peritoneal disease and intradermally in nude mice. Tumors ranged in size from a few hundred microns to several millimeters in diameter. Animals were intravenously administered (131)I-IAZGP and pimonidazole 2 h before sacrifice. Following sacrifice, the intratumoral distribution of (131)I-IAZGP was assessed by digital autoradiography and compared with immunofluorescence microscopic images of pimonidazole binding and carbonic anhydrase IX (CAIX) expression. RESULTS: The distributions of (131)I-IAZGP, pimonidazole, and CAIX expression were similar. Tumors less than 1 mm diameter displayed high (131)I-IAZGP uptake; these tumors also stained strongly for pimonidazole and CAIX. Larger tumors (approximately 1-4 mm diameter) were not significantly hypoxic and had low (131)I-IAZGP accumulation. CONCLUSION: (131)I-IAZGP can detect hypoxia in microscopic tumors. Microscopic tumors are useful models for the validation of hypoxia radiotracers, and digital autoradiography is an appropriate technique for studying the distribution of hypoxia radiotracers in microscopic tumors.
Authors: Joseph A O'Donoghue; Pat Zanzonico; Andrei Pugachev; Bixiu Wen; Peter Smith-Jones; Shangde Cai; Eva Burnazi; Ronald D Finn; Paul Burgman; Shutian Ruan; Jason S Lewis; Michael J Welch; C Clifton Ling; John L Humm Journal: Int J Radiat Oncol Biol Phys Date: 2005-04-01 Impact factor: 7.038
Authors: J A Raleigh; D P Calkins-Adams; L H Rinker; C A Ballenger; M C Weissler; W C Fowler; D B Novotny; M A Varia Journal: Cancer Res Date: 1998-09-01 Impact factor: 12.701
Authors: Andrei Pugachev; Shutian Ruan; Sean Carlin; Steven M Larson; Jose Campa; C Clifton Ling; John L Humm Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-01 Impact factor: 7.038
Authors: Pat Zanzonico; Joseph O'Donoghue; J Donald Chapman; Richard Schneider; Shangde Cai; Steven Larson; Bixiu Wen; Yuchun Chen; Ronald Finn; Shutian Ruan; Leo Gerweck; John Humm; Clifton Ling Journal: Eur J Nucl Med Mol Imaging Date: 2003-10-02 Impact factor: 9.236
Authors: L Dubois; W Landuyt; K Haustermans; P Dupont; G Bormans; P Vermaelen; P Flamen; E Verbeken; L Mortelmans Journal: Br J Cancer Date: 2004-11-29 Impact factor: 7.640
Authors: Xiao-Feng Li; Yuanyuan Ma; Xiaorong Sun; John L Humm; C Clifton Ling; Joseph A O'Donoghue Journal: J Nucl Med Date: 2010-04 Impact factor: 10.057
Authors: R P Mason; D Zhao; J Pacheco-Torres; W Cui; V D Kodibagkar; P K Gulaka; G Hao; P Thorpe; E W Hahn; P Peschke Journal: Q J Nucl Med Mol Imaging Date: 2010-06 Impact factor: 2.346
Authors: Tao Huang; A Cahid Civelek; Huaiyu Zheng; Chin K Ng; Xiaoxian Duan; Junling Li; Gregory C Postel; Baozhong Shen; Xiao-Feng Li Journal: Am J Nucl Med Mol Imaging Date: 2013-03-08
Authors: Joseph A O'Donoghue; José G Guillem; Heiko Schöder; Nancy Y Lee; Chaitanya R Divgi; Jeannine A Ruby; John L Humm; Steven A Lee-Kong; Eva M Burnazi; Shangde Cai; Sean D Carlin; Tobias Leibold; Pat B Zanzonico; C Clifton Ling Journal: EJNMMI Res Date: 2013-06-03 Impact factor: 3.138